Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Caladrius Biosciences Inc banner
C

Caladrius Biosciences Inc
LSE:0HS8

Watchlist Manager
Caladrius Biosciences Inc
LSE:0HS8
Watchlist
Price: 4.61 USD 1.73% Market Closed
Market Cap: $89.3m
Write Note Create Alert Ask AI

Caladrius Biosciences Inc
Investor Relations

Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. The company is headquartered in Basking Ridge, New Jersey and currently employs 27 full-time employees. The firm is developing therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. The Company’s product candidates include CLBS16, CLBS12 and CLBS201. The CLBS16 (XOWNA) is an experimental regenerative medicine that is being studied in a Phase IIb study (the FREEDOM trial) in the United States for the treatment of coronary microvascular dysfunction. The CLBS12 (HONEDRA) is an experimental regenerative medicine being studied in Japan for the prevention of serious adverse consequences of critical limb ischemia. The CLBS201 is an experimental regenerative medicine designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for diabetic kidney disease.

Show more
Loading
0HS8
S&P 500
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 6, 2025
Q3 2025 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Earnings Call Recording
Open Transcript
Other Earnings Calls

Management

Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
President, CEO & Director
No Bio Available
Dr. Kristen K. Buck M.D.
Executive VP of R&D and Chief Medical Officer
No Bio Available
Mr. James Nisco
Senior VP of Finance, Treasurer, CAO & Principal Financial and Accounting Officer
No Bio Available
Mr. Tariq Imam
Vice President of Business Development & Operations and Corporate Counsel
No Bio Available
Mr. Gregory S. Berkin
Chief Information & Data Protection Officer
No Bio Available
Mr. John D. Menditto
Vice President of Investor Relations & Corporate Communications
No Bio Available
Ms. Gail Holler
Vice President of Human Resources
No Bio Available
Dr. William K. Sietsema Ph.D.
Vice President of Global Regulatory Affairs
No Bio Available

Contacts

Address
NEW JERSEY
Basking Ridge
110 Allen Road, Second Floor
Contacts
+19082292590.0
www.caladrius.com
sparklesyt

See Also

Summary
0HS8 intrinsic value, competitors valuation, and company profile.
DCF Valuation
0HS8 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0HS8 stock valuation using valuation multiples.
Wall Street Estimates
0HS8 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0HS8 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 318,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.